Search

1. Eculizumab and efgartigimod for the treatment of myasthenia gravis: effectiveness and value : final report

Author(s):

Tice, Jeffrey A., author
Touchette, Daniel R., author
Nikitin, Dmitriy, author
Campbell, Jon, author
Lien, Pei-Wen, author
Moradi, Ashton, author
Rind, David M., author
Pearson, Steven D., author
Agboola, Foluso, author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, October 20, 2021

Subject(s):

Immunosuppressive Agents
Myasthenia Gravis -- drug therapy
United States

2. Tezepelumab for severe asthma: final report

Author(s):

Rind, David M., author
McQueen, Brett, author
Herron-Smith, Serina, author
Herce-Hagiwara, Belén, author
Gutierrez, Éric, author
Campbell, Jon, author
Fluetsch, Noemi, author
Pearson, Steven D., author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, December 16, 2021

Subject(s):

Antibodies, Monoclonal, Humanized
Asthma -- drug therapy
United States

3. Aducanumab for Alzheimer’s disease: effectiveness and value : final evidence report and meeting summary

Author(s):

Lin, Grace A., author
Whittington, Melanie D., author
Synnott, Patricia G., author
McKenna, Avery, author
Campbell, Jon, author
Pearson, Steven D., author
Rind, David M., author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, August 5, 2021

Subject(s):

Alzheimer Disease -- drug therapy
Antibodies, Monoclonal
United States